CA9 and renal cell carcinoma: In a humanised mouse model of CAIX+PDL1+ RCC, anti-CAIX-CAR secreting anti-PDL1 showed superior anti-tumour activity and reduced expression of the T-cell exhaustion markers than the control groups.